COGNIFIRM ApS: Financial statements 2022
CVR: 41722932
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
COGNIFIRM ApS (CVR 41722932) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 199,000 and a net result of DKK -537,172 compared with DKK -30,155 the year before. The profit margin was -269.9%. Equity in the 2022 report amounted to DKK -370,140.
- Revenue
- DKK 199,000
- Gross Profit
- DKK -540,580
- Profit/Loss
- DKK -537,172
- Equity
- DKK -370,140
- Total Assets
- DKK 1,012,713
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 199 t. | -541 t. | -537 t. | -370 t. | - |
| 2021 | - | -37 t. | -30 t. | 10 t. | - |
Official annual report
Keep an eye on COGNIFIRM ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 1, 2022, Lars Barthold Nielsen has stepped down as director of COGNIFIRM ApS.
COGNIFIRM ApS has published its annual report for 2021. Gross profit came to DKK -37,270, and the net result was DKK -30,155.
About COGNIFIRM ApS
COGNIFIRM ApS was a Danish company of the type Anpartsselskab based in Virum, founded in 2020. The company has been dissolved on 16 December 2024. The company was registered under the industry Computerprogrammering. In 2022, the company reported revenue of DKK 199,000 and a net result of DKK -537,172 compared with DKK -30,155 the year before. Equity in the 2022 report amounted to DKK -370,140.